tiprankstipranks
Trending News
More News >
IQ-AI Limited (GB:IQAI)
LSE:IQAI

IQ-AI (IQAI) Price & Analysis

Compare
6 Followers

IQAI Stock Chart & Stats


Financials

Options Prices

Currently, No data available
---

Ownership Overview

25.29%74.71%
25.29%
Insiders
Mutual Funds
― Other Institutional Investors
74.71% Public Companies and
Individual Investors

IQAI FAQ

What was IQ-AI Limited’s price range in the past 12 months?
IQ-AI Limited lowest share price was 0.72p and its highest was 2.10p in the past 12 months.
    What is IQ-AI Limited’s market cap?
    IQ-AI Limited’s market cap is £2.04M.
      When is IQ-AI Limited’s upcoming earnings report date?
      IQ-AI Limited’s upcoming earnings report date is Aug 19, 2025 which is in 82 days.
        How were IQ-AI Limited’s earnings last quarter?
        IQ-AI Limited released its earnings results on Apr 25, 2025. The company reported 0p earnings per share for the quarter, the consensus estimate of N/A by 0p.
          Is IQ-AI Limited overvalued?
          According to Wall Street analysts IQ-AI Limited’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
            Does IQ-AI Limited pay dividends?
            IQ-AI Limited pays a Notavailable dividend of 0.8p which represents an annual dividend yield of N/A. See more information on IQ-AI Limited dividends here
              What is IQ-AI Limited’s EPS estimate?
              IQ-AI Limited’s EPS estimate for its next earnings report is not yet available.
              How many shares outstanding does IQ-AI Limited have?
              IQ-AI Limited has 246,709,800 shares outstanding.
                What happened to IQ-AI Limited’s price movement after its last earnings report?
                IQ-AI Limited reported an EPS of 0p in its last earnings report, expectations of N/A. Following the earnings report the stock price went same 0%.
                  Which hedge fund is a major shareholder of IQ-AI Limited?
                  Currently, no hedge funds are holding shares in GB:IQAI

                  Company Description

                  IQ-AI Limited

                  IQ-AI Limited, through its subsidiaries, develops software applications for the healthcare industry in Jersey and the United States. Its products include IB Clinic, a toolkit of post-processing software plug-ins for integrating into existing medical image visualization applications; IB Rad Tech, a workflow engine that processes customized workflows; IB Neuro, which analyzes MR data sets and generates parametric perfusion maps quantifying changes in contrast over time; and IB Delta Suite that performs a various fundamental radiology operations, including image co-registration, subtraction, class map generation, and export. The company also offers IB DCE, which analyzes conventional T1 weighted images and generates an array of relevant perfusion and permeability parameters; IB Diffusion that analyzes MR diffusion-weighted images and generates apparent diffusion coefficient, extrapolated b-value, IVIM, and other parameter maps; and IB StoneChecker, a medical software tool to aid clinical decision making by providing information about a patient's kidney stone. In addition, it provides consulting services. The company was formerly known as Flying Brands Limited and changed its name to IQ-AI Limited in October 2018. IQ-AI Limited is based in Saint Helier, Jersey.
                  Similar Stocks
                  Company
                  Price & Change
                  Follow
                  Creo Medical
                  IXICO plc
                  Oxford BioDynamics
                  Polarean Imaging
                  Induction Healthcare Group Plc
                  Popular Stocks
                  What am I Missing?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis